English, Excel, 4,115kb
Download this selection of key indicators from OECD Health Statistics 2016, in Excel. 2016 version, updated 30 June 2016.
Australia’s health system functions remarkably well, despite operating under a complex set of institutions that make coordinating patient care difficult. Complications arising from a split in federal and state government funding and responsibilities are central to these challenges. This fragmented health care system can disrupt the continuity of patient care, lead to a duplication of services and leave gaps in care provision. Supervision of these health services by different levels of government can manifest in avoidable impediments such as the poor transfer of health information, and pose difficulties for patients navigating the health system. Adding to the Australian system’s complexity is a mix of services delivered through both the public and private sectors. To ease health system fragmentation and promote more integrated services, Australia should adopt a national approach to quality and performance through an enhanced federal government role in steering policy, funding and priority setting. The states, in turn, should take on a strengthened role as health service providers, with responsibility for primary care devolved to the states to better align it with hospital services and community care. A more strategic role for the centre should also leave room for the strategic development of health services at the regional level, encouraging innovation that is responsive to local population need, particularly in rural and remote areas.
Over the past decade, many OECD countries have introduced new policies to tackle excessive waiting times for elective treatments with some success. However, in the wake of the recent economic downturn and severe pressures on public budgets, waiting times may rise again, and it is important to understand which policies work.
Cette nouvelle édition du Panorama de la santé présente les données comparables les plus récentes sur les principaux indicateurs de la santé et des systèmes de santé des pays membres de l’OCDE. Pour un sous-groupe d’indicateurs, elle contient aussi des données se rapportant à des pays partenaires dont l'Afrique du Sud, le Brésil, la Chine, la Colombie, le Costa Rica, la Fédération de Russie, l'Inde, l'Indonésie, la Lettonie et la Lituanie. Cette édition contient deux nouveautés : une série de tableaux de bord qui résument la performance des pays de l’OCDE sur des indicateurs clés de santé et des systèmes de santé, et un chapitre spécial sur les tendances récentes des dépenses pharmaceutiques parmi les pays de l’OCDE. Cette édition contient également de nouveaux indicateurs sur la migration du personnel de santé et sur la qualité des soins de santé.
De trop nombreuses vies sont encore perdues parce que la qualité des services de santé s’améliore trop lentement pour faire face au vieillissement des populations et au nombre croissant de personnes souffrant d’une ou de plusieurs maladies chroniques, selon un nouveau rapport de l'OCDE.
Français, PDF, 1,736kb
Principaux résultats sur le système de santé français
The book presents a background study of DRG-based payment systems, drawing on the experience of implementing such hospital funding arrangements internationally, including an overview of developments in the Asia and Pacific region. It underscores the need for countries to be clear about their purpose and objective for introducing Diagnosis Related Groups, as well as their place in health-care financing reform, and for policy-makers to reflect on the importance of country-specific starting points, objectives and context in which the hospital payment reforms are being implemented. Chapter 4 – written by Yuki Murakami and Luca Lorenzoni – investigates the evidence regarding the impact on cost, quality and efficiency of the introduction of a DRG-based payment system.
Antimicrobial therapies have played an essential role in the treatment of infections in humans and animals and have significantly improved population health. All these applications are now endangered by the increasing spread of microbes that are resistant to antimicrobial medications. The OECD will present during the G7 Health Ministers Meeting in Berlin on October 8 some key findings and policy recommendations on how to deal with AMR.
All countries are investing in health data. There are however significant cross-country differences in data availability and use. Some countries stand out for their innovative practices enabling privacy-protective data use while others are falling behind with insufficient data and restrictions that limit access to and use of data, even by government itself. Countries that develop a data governance framework that enables privacy-protective data use will not only have the information needed to promote quality, efficiency and performance in their health systems, they will become a more attractive centre for medical research. After examining the current situation in OECD countries, a multi-disciplinary advisory panel of experts identified eight key data governance mechanisms to maximise benefits to patients and to societies from the collection, linkage and analysis of health data and to, at the same time, minimise risks to the privacy of patients and to the security of health data. These mechanisms include coordinated development of high-value, privacy-protective health information systems, legislation that permits privacy-protective data use, open and transparent public communication, accreditation or certification of health data processors, transparent and fair project approval processes, data de-identification and data security practices that meet legal requirements and public expectations without compromising data utility and a process to continually assess and renew the data governance framework as new data and new risks emerge.
The health systems we enjoy today, and expected medical advances in the future, will be difficult to finance from public resources without major reforms. Public health spending in OECD countries has grown rapidly over most of the last half century. These spending increases have contributed to important progress in population health: for example, life expectancy at birth has increased, rising on average by ten years since 1970. The challenge now is to sustain and enhance these achievements in a context of tight fiscal constraints in many countries combined with upward pressure on health spending from factors such as new technological advances and demographic changes. Finding policies that can make health spending more sustainable without compromising important achievements in access and quality requires effective co-operation between health and finance ministries. Sound governance and co-ordination mechanisms are therefore essential to ensure effective policy choices. Prepared by both public finance and health experts, this report provides a unique detailed overview of institutional frameworks for financing health care in OECD countries. One of the main features of this book is a comprehensive mapping of budgeting practices and governance structure in health across OECD countries.